Logo image of CRWV

COREWEAVE INC-CL A (CRWV) Stock Fundamental Analysis

NASDAQ:CRWV - Nasdaq - US21873S1087 - Common Stock - Currency: USD

80.3  +14.53 (+22.09%)

After market: 76.411 -3.89 (-4.84%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CRWV. CRWV was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of CRWV have multiple concerns. CRWV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CRWV had negative earnings in the past year.
CRWV Yearly Net Income VS EBIT VS OCF VS FCFCRWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

CRWV's Return On Assets of -6.63% is on the low side compared to the rest of the industry. CRWV is outperformed by 67.07% of its industry peers.
CRWV's Return On Equity of -68.03% is on the low side compared to the rest of the industry. CRWV is outperformed by 78.05% of its industry peers.
CRWV has a Return On Invested Capital of 2.52%. This is comparable to the rest of the industry: CRWV outperforms 51.22% of its industry peers.
Industry RankSector Rank
ROA -6.63%
ROE -68.03%
ROIC 2.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRWV Yearly ROA, ROE, ROICCRWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 200 300 400

1.3 Margins

CRWV has a better Operating Margin (16.93%) than 91.46% of its industry peers.
Looking at the Gross Margin, with a value of 74.24%, CRWV belongs to the top of the industry, outperforming 91.46% of the companies in the same industry.
Industry RankSector Rank
OM 16.93%
PM (TTM) N/A
GM 74.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRWV Yearly Profit, Operating, Gross MarginsCRWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRWV is destroying value.
Compared to 1 year ago, CRWV has about the same amount of shares outstanding.
The debt/assets ratio for CRWV is higher compared to a year ago.
CRWV Yearly Shares OutstandingCRWV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M
CRWV Yearly Total Debt VS Total AssetsCRWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that CRWV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.34, CRWV is not doing good in the industry: 64.63% of the companies in the same industry are doing better.
CRWV has a Debt/Equity ratio of 2.51. This is a high value indicating a heavy dependency on external financing.
CRWV has a worse Debt to Equity ratio (2.51) than 79.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.26
WACC9.61%
CRWV Yearly LT Debt VS Equity VS FCFCRWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2B -2B 4B -4B

2.3 Liquidity

A Current Ratio of 0.52 indicates that CRWV may have some problems paying its short term obligations.
CRWV has a worse Current ratio (0.52) than 90.24% of its industry peers.
CRWV has a Quick Ratio of 0.52. This is a bad value and indicates that CRWV is not financially healthy enough and could expect problems in meeting its short term obligations.
CRWV has a worse Quick ratio (0.52) than 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
CRWV Yearly Current Assets VS Current LiabilitesCRWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

CRWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.81%.
CRWV shows a strong growth in Revenue. In the last year, the Revenue has grown by 736.64%.
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%544.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
CRWV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.40% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year144.33%
Revenue Next 2Y139.41%
Revenue Next 3Y101.4%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
CRWV Yearly Revenue VS EstimatesCRWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 5B 10B 15B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRWV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRWV Price Earnings VS Forward Price EarningsCRWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

CRWV's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.33
CRWV Per share dataCRWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRWV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COREWEAVE INC-CL A

NASDAQ:CRWV (5/16/2025, 6:48:10 PM)

After market: 76.411 -3.89 (-4.84%)

80.3

+14.53 (+22.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change75.51%
Market Cap37.27B
Analysts77
Price Target47.77 (-40.51%)
Short Float %4.77%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.46
P/FCF N/A
P/OCF N/A
P/B 27.04
P/tB 27.54
EV/EBITDA 28.33
EPS(TTM)-2.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.13
BVpS2.97
TBVpS2.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.63%
ROE -68.03%
ROCE 3.19%
ROIC 2.52%
ROICexc 2.91%
ROICexgc 2.92%
OM 16.93%
PM (TTM) N/A
GM 74.24%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF N/A
Debt/EBITDA 2.91
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 1.34
F-ScoreN/A
WACC9.61%
ROIC/WACC0.26
Cap/Depr(3y)1492.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)732.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%544.35%
Revenue Next Year144.33%
Revenue Next 2Y139.41%
Revenue Next 3Y101.4%
Revenue Next 5YN/A
EBIT growth 1Y2344.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-436.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.01%
OCF growth 3YN/A
OCF growth 5YN/A